CDGLY yields 5.05% · PFE yields 6.13%● Live data
📍 CDGLY pulled ahead of the other in Year 1
Combined, CDGLY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CDGLY + PFE for your $10,000?
ComfortDelGro Corporation Limited, an investment holding company, provides public transport services in Singapore. It operates through seven segments: Public Transport Services, Taxi, Automotive Engineering Services, Inspection and Testing Services, Driving Centre, Car Rental and Leasing, and Bus Station. The company offers bus and rail services to commuters; taxi and coach rental, and related advertisement services; non-emergency transport services to patients; vehicular maintenance and repair services; assembly of bus bodies; crash repair services; and engineering services, as well as sells diesel and petrol. It is also involved in the provision of motor vehicle inspection, non-vehicle testing, inspection, and consultancy services; construction of specialized vehicles; operation of taxi bureau, scheduled services, and driving schools; electric vehicle charging infrastructure activities; and renting and leasing of cars. In addition, the company offers public taxi and charter bus, management of taxi booking, building inspection, technology, and terminal services; and operates workshops for repairing, servicing, and general maintenance of motor vehicles. Further, it provides insurance broking, risk management, claims management, and related services; medical escort services; charge card facilities; and accident and other repair and maintenance services. As of March 30, 2022, the company operated a fleet of 35,000 buses, taxis, and rental vehicles. It also operates in the United Kingdom, Ireland, Australia, China, New Zealand, and Malaysia. ComfortDelGro Corporation Limited was incorporated in 2003 and is headquartered in Singapore.
Full CDGLY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.